| Year |
Citation |
Score |
| 2021 |
Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, ... ... Davis BJ, et al. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. European Urology. PMID 33985797 DOI: 10.1016/j.eururo.2021.04.035 |
0.303 |
|
| 2020 |
Valle L, Lehrer E, Karnes R, Reiter R, Rettig M, Calais J, Nickols N, Spratt D, Dess R, Steinberg M, Nguyen P, Davis B, Zarosky N, Kishan A. Meta-Analysis of Salvage Therapy Following Definitive Radiotherapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 108: e875. DOI: 10.1016/j.ijrobp.2020.07.459 |
0.3 |
|
| 2018 |
Stish BJ, Davis BJ, Mynderse LA, McLaren RH, Deufel CL, Choo R. Low dose rate prostate brachytherapy. Translational Andrology and Urology. 7: 341-356. PMID 30050795 DOI: 10.21037/tau.2017.12.15 |
0.304 |
|
| 2018 |
Lieng H, Hayden AJ, Christie DRH, Davis BJ, Eade TN, Emmett L, Holt T, Hruby G, Pryor D, Shakespeare TP, Sidhom M, Skala M, Wiltshire K, Yaxley J, Kneebone A. Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 30037499 DOI: 10.1016/j.radonc.2018.06.027 |
0.304 |
|
| 2017 |
Stish BJ, Davis BJ, Mynderse LA, Deufel CL, Choo R. Brachytherapy in the Management of Prostate Cancer. Surgical Oncology Clinics of North America. 26: 491-513. PMID 28576185 DOI: 10.1016/j.soc.2017.01.008 |
0.312 |
|
| 2017 |
Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, et al. ACR Appropriateness Criteria(®) Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. Journal of the American College of Radiology : Jacr. 14: S245-S257. PMID 28473080 DOI: 10.1016/j.jacr.2017.02.026 |
0.3 |
|
| 2016 |
Jethwa KR, Furutani KM, Mynderse LA, Wilson TM, Choo R, King BF, Bergstralh E, Davis BJ. Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression. Journal of Contemporary Brachytherapy. 8: 371-378. PMID 27895677 DOI: 10.5114/jcb.2016.63377 |
0.301 |
|
| 2015 |
Spratt DE, Evans MJ, Davis BJ, Doran MG, Lee MX, Shah N, Wongvipat J, Carnazza KE, Klee GG, Polkinghorn W, Tindall DJ, Lewis JS, Sawyers CL. Androgen receptor upregulation mediates radioresistance after ionizing radiation. Cancer Research. PMID 26432404 DOI: 10.1158/0008-5472.Can-15-0892 |
0.303 |
|
| 2010 |
Davis B, Tang J, Zhang L, Mu D, Jiang X, Biran V, Vexler Z, Ferriero DM. Role of vasodilator stimulated phosphoprotein in VEGF induced blood-brain barrier permeability in endothelial cell monolayers. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 28: 423-8. PMID 20599605 DOI: 10.1016/J.Ijdevneu.2010.06.010 |
0.343 |
|
| 2005 |
Chrouser KL, Leibovich BC, Sweat SD, Larson DW, Davis BJ, Tran NV, Zincke H, Blute ML. Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer. The Journal of Urology. 173: 1953-7. PMID 15879789 DOI: 10.1097/01.JU.0000158041.77063.FF |
0.309 |
|
| 2001 |
Holmes DR, Davis BJ, Robb RA. 3D localization of implanted radioactive sources in the prostate using trans-urethral ultrasound Studies in Health Technology and Informatics. 81: 199-205. PMID 2001138074 DOI: 10.3233/978-1-60750-925-7-199 |
0.302 |
|
| 2000 |
Leibovich BC, Blute ML, Bostwick DG, Wilson TM, Pisansky TM, Davis BJ, Ramnani DM, Cheng L, Sebo TJ, Zincke H. Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology. 56: 726-9. PMID 11068288 DOI: 10.1016/S0090-4295(00)00792-5 |
0.314 |
|
| Show low-probability matches. |